View Hideaki Negishi’s profile on LinkedIn, the world's largest professional community. Hideaki has 1 job listed on their profile. See the complete profile on LinkedIn and discover Hideaki’s connections and jobs at similar companies.
10 Masatoshi Hayashi, Teruo Inoue, Kazunori Hoshimoto, Hideaki Negishi, Takeyoshi Ohkura, Noriyuki Inaba, Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia, European Journal …
VIEW ARTICLE. | DOI: MPMI Pseudomonas solanacearum: Plasmid pJTPS1 Mediates a Shift from the Pathogenic to Nonpathogenic Phenotype.Hideaki Negishi. Japan Tobacco Inc., Applied Plant Research Laboratory, Yokohama Center, 6-2 Umegaoka, Midori-ku, Yokohama 227, Japan.
Masatoshi Hayashi, Teruo Inoue, Kazunori Hoshimoto, Hideaki Negishi, Takeyoshi Ohkura and Noriyuki Inaba, Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre‐eclampsia, European Journal of …
Yasushi Sasaki Hideaki Negishi Masashi Idogawa Hiromu Suzuki Hiroaki Mita Minoru Toyota Yasuhisa Shinomura Kohzoh Imai Takashi Tokino Mol Cancer Ther Apr;7(4): Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University School of Medicine, S-1, W-17, Chuo-ku, Sapporo, Japan.
Yasushi Sasaki, Hideaki Negishi, MasashiIdogawa,IkukoYokota,RyotaKoyama, Masanobu Kusano, Hiromu Suzuki, MasahiroFujita,ReoMaruyama,MinoruToyota, Tsuyoshi Saito, and Takashi Tokino Precis: Tumor suppressor genes may exert a significant part of their activity by regulating autocrine and paracrine growth factor pathways,
Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models Yasushi Sasaki,1,2 Hideaki Negishi,1 Masashi Idogawa,1,2 Hiromu Suzuki,1,2 Hiroaki Mita,1,2 Minoru Toyota,1,2 Yasuhisa Shinomura,2 Kohzoh Imai,2 and Takashi Tokino1 1Department of Molecular Biology, Cancer Research Institute, and 2First Department of Internal Medicine, Sapporo Medical